For people living with difficult-to-treat depression, when two or more antidepressants have not provided relief, Spravato® (esketamine) offers an alternative that works differently from traditional…
The FDA recently cleared Spravato® as the first nasal spray for difficult to treat depression, proving high effectiveness when other medications haven’t worked. Spravato® doesn’t…
More than 21 million adults in the United States experienced a major depressive episode in 2021, and over 30% of those people didn’t respond well…
Treatment-resistant depression (TRD) is typically diagnosed when someone has tried two or more antidepressant medications without experiencing significant improvements in symptoms. This can be frustrating…
Spravato®, a form of esketamine, is a prescription nasal spray that has been approved by the FDA for difficult-to-treat depression. Spravato® works differently than traditional…
Finding the right treatment for depression can be deeply personal, and for some, it’s not as simple as starting a new medication or attending therapy.…